EPA
- Half-Life (t½)
- PO: 18h
- Formula
- C20H30O2
- Molecular Weight
- 302.45 g/mol
- Aliases
- Eicosapentaenoic acid, C20:5n3
Pharmacological Mechanism
C20:5 ω-3 polyunsaturated fatty acid. Substrate for COX/LOX enzymes generating series-3 (less inflammatory) prostaglandins + thromboxanes + series-5 leukotrienes. Direct modulator of inflammatory gene expression via PPAR-α, FFAR4. Cardiovascular + triglyceride-lowering effects.
Half-Life & Elimination Curve (PO: 18h)
Elimination (PO)
- 0×t½0h100%
- 1×t½18h50%
- 2×t½36h25%
- 3×t½54h12.5%
- 4×t½3d6.3%
- 5×t½3.8d3.1%
Dosing Guidelines
- Oral (PO): Typical 1000 mg (Range: 500–4000 mg)
Pathways It Modulates
Target Organ Systems
- Cardiovascular System
- Immune & Hematologic
Top Dietary Sources
Chemical Structure & Identifiers
- InChIKey: JAZBEHYOTPTENJ-JLNKQSITSA-N
- SMILES: CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O